SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-23-000032
Filing Date
2023-03-20
Accepted
2023-03-20 17:16:58
Documents
12
Period of Report
2023-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K isee-20230314.htm   iXBRL 8-K 29858
  Complete submission text file 0001410939-23-000032.txt   157197

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20230314.xsd EX-101.SCH 1921
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20230314_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20230314_pre.xml EX-101.PRE 12525
6 EXTRACTED XBRL INSTANCE DOCUMENT isee-20230314_htm.xml XML 4095
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 23747137
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences